iANTHUS CAPITAL HOLDINGS (ITHUF) Income towards Parent Company (2020 - 2026)

iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Income towards Parent Company came in at -$14.3 million in Q1 2026, down 377.84% year-on-year from $5.1 million in Q1 2025, and down 1.55% quarter-over-quarter from -$14.1 million in Q4 2025.

iANTHUS CAPITAL HOLDINGS (ITHUF) Income towards Parent Company (2020 - 2026) Analysis & Trends

iANTHUS CAPITAL HOLDINGS has disclosed Income towards Parent Company across 7 years of filings, most recently posting -$14.3 million for Q1 2026.

  • Income towards Parent Company for Q1 2026 came in at -$14.3 million, down 377.84% year-over-year; the trailing twelve-month figure through Mar 2026 was -$59.7 million (down 580.92% YoY), and the FY2025 annual result was -$40.2 million, down 44.05% from the prior year.
  • Income towards Parent Company came in at -$14.3 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from -$14.1 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $7.5 million in Q4 2024 to a low of -$373.6 million in Q2 2022.
  • The 5-year median for Income towards Parent Company is -$14.3 million (2026), against an average of -$35.8 million.
  • Across the five-year window, Income towards Parent Company sank 2348.62% in 2022 and jumped 140.22% in 2024, its largest moves.
  • iANTHUS CAPITAL HOLDINGS's Income towards Parent Company stood at -$43.7 million in 2022, then surged by 57.25% to -$18.7 million in 2023, then jumped by 140.22% to $7.5 million in 2024, then slumped by 287.39% to -$14.1 million in 2025, then retreated by 1.55% to -$14.3 million in 2026.
  • The last three Income towards Parent Company figures came in at -$14.3 million (Q1 2026), -$14.1 million (Q4 2025), and -$12.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 iANTHUS CAPITAL HOLDINGS - - 15.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.31 Mn
Dec 31, 2025 -14.09 Mn
Sep 30, 2025 -12.55 Mn
Jun 30, 2025 -18.72 Mn
Mar 31, 2025 5.15 Mn
Dec 31, 2024 7.52 Mn
Sep 30, 2024 -11.64 Mn
Jun 30, 2024 -9.79 Mn
Mar 31, 2024 -14.00 Mn
Dec 31, 2023 -18.70 Mn
Sep 30, 2023 -19.18 Mn
Jun 30, 2023 -20.15 Mn
Mar 31, 2023 -18.60 Mn
Dec 31, 2022 -43.73 Mn
Sep 30, 2022 -22.00 Mn
Jun 30, 2022 -373.56 Mn
Mar 31, 2022 -10.10 Mn
Dec 31, 2021 -26.95 Mn
Sep 30, 2021 -15.84 Mn
Jun 30, 2021 -15.26 Mn